Back
89bio Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
40
ETNB
89bio
Last Price:
8.38
Seasonality Move:
-3.05%
Buy
62
MDGL
Madrigal Pharmaceuticals
Last Price:
329.17
Seasonality Move:
43.27%
Sell
40
89bio (ETNB)
is a Sell
Is 89bio a Buy, Sell or Hold?
- The current 89bio [ETNB] share price is $8.38. The Score for ETNB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ETNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $329.24. The Score for MDGL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $329.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ETNB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | 243475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.79 - 9.43) | Sell |
| Bollinger Bands (100): | (7.64 - 9.08) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.6 | Buy |
| Relative Strength Index (14 RSI): | 65.18 | Buy |
| Chaikin Money Flow: | 384000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.75 - 338.03) | Buy |
| Bollinger Bands (100): | (217.96 - 295.58) | Buy |
ETNB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.37 | Buy |
| 20-day SMA: | 8.76 | Sell |
| 50-day SMA: | 8.17 | Buy |
| 200-day SMA: | 9.07 | Sell |
| 8-day EMA: | 8.42 | Sell |
| 20-day EMA: | 8.56 | Sell |
| 50-day EMA: | 8.42 | Sell |
| 200-day EMA: | 9.1 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 313.71 | Buy |
| 20-day SMA: | 300.12 | Buy |
| 50-day SMA: | 250.78 | Buy |
| 200-day SMA: | 248.28 | Buy |
| 8-day EMA: | 316.12 | Buy |
| 20-day EMA: | 298.64 | Buy |
| 50-day EMA: | 270.37 | Buy |
| 200-day EMA: | 246.37 | Buy |
89bio Earnings Growth & ETNB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.96 per share, and an increase next year of $0.11 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.10 per share, and an increase next year of $10.03 per share.
89bio Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||